As of Tuesday noon (13 Oct), the Ministry of Health (MOH) has confirmed four new cases of COVID-19 infection.

This brings the total number of infection cases to 57,884.

There are no new cases of locally transmitted COVID-19 infection.

However, there are four new imported cases, who had all been placed on Stay-Home Notice upon arrival in Singapore.

Amongst the new cases today, 3 are asymptomatic and were detected from screening and surveillance, while 1 was symptomatic.

All the new cases today are imported or linked to known cases/ clusters.

There are no new cases detected in dormitories for the first time since 25 March 2020.

MOH stated that it has been monitoring existing clusters for any further transmission. As there have been no more cases linked to the cluster at Mandai Lodge I (460 Mandai Road) for the past two incubation periods (i.e. 28 days), the cluster has now been closed.

There are no new cases linked to existing or new clusters today

Update on condition of confirmed cases

12 more cases of COVID-19 infection have been discharged from hospitals or community isolation facilities. In all, 57,740 have fully recovered from the infection and have been discharged from hospitals or community care facilities.

There are currently 35 confirmed cases who are still in the hospital. Of these, most are stable or improving, and none is in the intensive care unit. 81 are isolated and cared for at community facilities. These are those who have mild symptoms, or are clinically well but still test positive for COVID-19.

28 have passed away from complications due to COVID-19 infection.

 

 

Subscribe
Notify of
1 Comment
Newest
Oldest Most Voted
Inline Feedbacks
View all comments
You May Also Like

EU to rule on J&J shot safety as raging virus wave grips India

by AFP Bureaus Europe’s drug regulator was expected to rule Tuesday on…

S’pore records 334 new COVID-19 cases, reaches total tally of 3,252

Singapore recorded 334 new COVID-19 cases, announced late Tue evening (14 Apr).…

US becomes first country to approve Respiratory Syncytial Virus (RSV) vaccine

The US has approved the world’s first vaccine for Respiratory Syncytial Virus (RSV), with drugmaker GSK’s Arexvy being green-lighted for adults aged 60 and older. RSV is a common virus that can be serious for infants, the elderly, and those with weak immune systems. Other vaccine makers, including Pfizer and Moderna, are expected to follow soon. Rates of RSV and flu fell during COVID-19 lockdowns, but surged when restrictions were lifted, with young children hit hard.